Detection and Analysis the HPV16 Integration in the Specimens of the Cervical Carcinoma and the Cell Line Siha

CHEN Lin, ZHENG Ying

Abstract

To build the viral integration sites map and verify the integration sites at or near the fragile site. Methods PCR method were applied to screen single HPV16 infected cervical carcinoma specimen and the viral integration sites in the specimens of cervical carcinomas and the cell line cells were detected by detection of integrated papillomavirus seguences by ligation-mediated PCR (DIPS-PCR). Results The integration site in cell line Siha was 13q22. The integration sites in the specimens of the cervical cancinomas were randomly located in chromosome 1, 3, 5, 6, 8, 10, 11, 13, 14, 15, 17, 19 as well as in X, but the sites were most likely at or near the chromosome fragile site. The location of the integration sites were at 1p35.1, 5p15.3, 10q24, 13q21-q22 and Xp11.4. By using the softwares CBS prediction servers and BDGP Neural Network Promoter prediction we found that the integration sites were located at the promoter like sequencs. Conclusion DIPS-PCR can detect the viral integration sites, and the sites are at or near the chromosome fragile sites, and the integration sites may including the promoter to amplify the virus oncogene.

 

Keywords: Cervical carcinoma, High-risk human papillomavirus, DIPS-PCR Integration, Fragile sites, Promoters 

 

Full Text:

PDF


References


SONG SH. Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix. Gynecol Cancer, 2006,16 (4): 1608-1613.

VINOKUROVA S. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Research. 2008,68(1): 307-313.

KOSHIOL J. LINDSAY U PIMENTA JM. persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Epidemioll, 2008, 168 (2); 123-137.

NAKAGAWAJT, SCHIRMER J, BARBIERI M. Human papillomavirus ( HPV) and uterine cervical cancer. Rev Bras Enferm,2010,63(2):307-311.

LU X. LIN Q. LIN M. et al. Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and celluar genes are asssociated with the development of cervical cancer. PLoS One,2014 ,9( 7); e97588[2016-01-15]. http://dx. doi. org/10. 1371/journal, pone. 0097588.

SHUKLA S, МАНАТА S, SHISHODIA G. Physical stated-copy number of high risk human papillomavirus typel6 DNA in progression of cervical cancer. Indian J Med Res, 2014,139(4);531-543.

WILLIAMS VM. HPV-DNA integration and carcinogenesis; putative roles for inflammation and oxidative stress. Future ViroloL2011,6(1); 45-57.

SIRINART A, ARKOM C, TIPAYA E. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas. Med Virol,2014,86(11) ; 1911-1919.

HUANG LW, CHAO SL, LEE BH. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. Clin Pathol.2008,61(5);627-631.

PETT M. COLEMAN N. Integration of high-risk human papillomavirus;a key event in cervical carcinogenesis. Pathol, 2007,212(4):356-367.

WENTZENSEN N, VINOKUROVA S, VON KNEBEL DOEBERITZ M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res,2004,64(11):3878-3884.

PETER M, ROSTY C, COUTURIER J, et al. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene,2006,25(44):5985- 5993.

THORLAND EC, MYERS SL. PERSING DH. et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res, 2000, 60(21);5916-5921.

MATOVINA M, SABOL I, GRUBISIC G, et al. Identification of human papillomavirustype 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol, 2009,113(1): 120-127.

DALLKL, SCARPINI CG, ROBERTS I, et al. Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res, 2008, 68 ( 20); 8249- 8259.

THORLAND EC, MYERS SL, GOSTOUT BS. et al. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene,2003,22(8):1225- 1237.

YU T, FERBER MJ, CHEUNG TH.et al. The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet, 2005,158 (1): 27-34.

AKAGIK, LI J, BROUTIAN TR, et al. genome-wide analysis of HPV integration in human cancer reveals reurrent, focal genomic instability. Genome Res, 2014,24 (2):185-199.

CHENG AM, BYROM MW. SHELTON J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res, 2005,33(6): 1290-1297.

MARTINEZ I, GARDINER AS, BOARD KF,et al. Human papillomavirus type 16 reduces the expression of microRNA- 218 in cervical carcinoma cells. Oncogene.2008.27(5):2575- 2582.

VOLINIAS, CALIN GA, LIU CG, el at. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Nat Acad Sci U S A,2006,103(4):2257- 2261.

LUFT F, KLAES R, NEES M, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR ( DIPS- PCR) and molecular characterization in cervical cancer cells. Int Cancer,2001,92(1);9-17.

LI N, FRANCESCHI S, HOWELL-JONES R. et al. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide;Variation by geographical region, histological type and year of publication. Int Cancer, 2011, 128(4):927-935.

FERBER MJ, THORLAND EC, BRINK AA, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene, 2003, 22 (46):7233-7242.

PETER M, STRANSKY N, COUTURIER J, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. Pathol,2010,221 (3) :320-330.

DIAOMK, LIU CY, LIU HW, et al. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and Si Ha cervical cancer cell lines. Life Sci, 2015 (127);46-52.

POULAMID, ASHA TH, UMESH M, et al. HPV genotyping and site of viral integration in cervical cancer in Indian women. PLoS One,2012,7(7): e41012[2016-01-16], http://dx. doi. org/10. 1371/journal, pone. 0041012.

SCHMITZ M. DRIESCH C, JANSEN L,etal. Non-random integration of the HPV genome in cervical cancer. PLoS One, 2012,7(6): e39632 [2016-01-16]. http://dx. doi. org/10. 1371 journal, pone. 0039632.

ADEY A, BURTON JN, KITZMAN JO , et al. The haplotype-resolved genome and epigenome of the aneuploid hela cancer cell line. Nature,2013,500(7461):207-211.

LI H, YANG Y, ZHANG R, et al. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. Clin Virol,2013,56(4) :342-347.

RICHARDS RI. Fragile and unstable chromosomes in cancer;causes and consequences. Trends Genet,2001 , 17(6): 339-345.

SMITH DI, HUANG H, WANG L. Common fragile sites and cancer. Int Oncol, 1998,12(1): 187-196.

MARTINA S, CORINA D, LARS J, et al. Non-random integration of the HPV genome in cervical cancer. PLoS One, 2012,7(6): e339632 [2016-01-16]. http://dx. doi. org/10. 1371/journal, pone. 0039632.


Refbacks

  • There are currently no refbacks.